The 5th Scientific Summit on Tobacco Harm Reduction: Novel products, Research & Policy, is organised by SCOHRE, the International Association on Smoking Control & Harm Reduction, on September 21 and 22, 2022, as a hybrid event: with physical presence in Athens, Greece, at the Stavros Niarchos Foundation Cultural Center, and virtual attendance.
The 5th Scientific Summit―following the works of a very successful virtual 4th Scientific Summit―aims to attract top researchers, clinicians, and scientists from diverse fields, from all over the world, to contribute to the Summit.
In 2021, due to the COVID-19 pandemic and its repercussions, the 4th Scientific Summit was organised virtually, thus enabling the participation of scientists from around the globe, namely, 62 renowned speakers from 31 countries and about 300 participants from 42 countries worldwide.
In previous Summits it was established that, during the last 30 years, the prevalence of smoking has decreased steadily around the globe. However, as populations have grown, the total number of smokers has increased. There is increasing interest on Tobacco Harm Reduction as a tool to reduce the detrimental consequences of cigarette smoking to the human population of the planet. However, more data is needed for politicians and public health regulators to make informed decisions.
All these and many more will be discussed in the two-day event on THR.
The objectives of the Summit are to offer opportunities for scientists of different countries to:
- Present, discuss, and challenge recent data related to the benefits and the risks associated with alternative tobacco product use among smokers and the association with switch and quit attempts.
- Discuss and debate on scientific, technological, medical, regulatory, legal and policy issues for advancing the technical capacity of the participating countries.
- Provide an environment where regulatory authorities and policy makers may present to the scientific and medical communities their prospective course of action.
The scientific programme of the Summit will include plenary and keynote lectures, as well as oral and e-poster presentations, on the following specific topics:
Toxicology and aerosol chemistry || Biomarkers’ evaluation in animal or human studies || Preclinical evaluation || Epidemiology & Social Issues || Clinical Assessment and Harm Reduction || Public Health || Legal & Regulatory issues || Bioethics || Innovation & Novel Products || Smoking cessation || Educational issues in adolescence